AUS
NZ
UK
CA
USA
IND
Highlights
- Institutional ownership in Eli Lilly (NYSE:LLY) has seen an increase, with multiple firms adding to their positions.
- Empowered Funds LLC expanded its stake in the company by acquiring additional shares.
- A significant percentage of Eli Lilly's stock is held by institutional investors, indicating broad participation.
Eli Lilly operates in the pharmaceutical sector, specializing in innovative treatments for various medical conditions. The company has been a key player in the industry, continuously working on advancing healthcare solutions. Recent filings have shown notable activity from institutional investors, reflecting engagement from financial entities in the company's stock.
Institutional Activity in Eli Lilly
Empowered Funds LLC recently increased its holdings in Eli Lilly by adding more shares during the fourth quarter. The firm now owns a significant number of shares, making the stock one of its major holdings. This move aligns with the trend of growing institutional interest in Eli Lilly. The investment was recorded in the latest filing with the Securities & Exchange Commission.
Along with Empowered Funds LLC, several other institutional entities have modified their positions in Eli Lilly. Some firms have expanded their stakes, while others have initiated new positions in the company. These movements are part of broader portfolio adjustments by hedge funds and asset managers.
Other Institutional Stakeholders
Multiple financial firms have recently taken positions in Eli Lilly. Some institutions have added shares, while others have made initial investments. The latest reports indicate that a high percentage of the company's stock is now in the hands of institutions. Firms such as Peterson Financial Group Inc., MidAtlantic Capital Management Inc., and Highline Wealth Partners LLC have all made changes to their stakes in Eli Lilly.
Peterson Financial Group Inc. established a new position in Eli Lilly during the third quarter, adding shares to its portfolio. Similarly, MidAtlantic Capital Management Inc. initiated a stake, showing further institutional involvement in the company. Highline Wealth Partners LLC also expanded its position, increasing its shareholding during the fourth quarter.
Growth in Institutional Ownership
Cedar Mountain Advisors LLC and Kovitz Investment Group Partners LLC have also adjusted their holdings in Eli Lilly. Cedar Mountain Advisors LLC expanded its stake during the third quarter by acquiring additional shares. Kovitz Investment Group Partners LLC followed a similar path, adding more shares to its portfolio over the same period.
These investment moves highlight the continued interest in Eli Lilly among institutional stakeholders. According to reports, over 80% of Eli Lilly’s stock is now controlled by institutional investors. This significant level of ownership underscores the pharmaceutical company's presence in various investment portfolios.
Final Thoughts on Institutional Interest
The increased engagement from institutional investors reflects sustained activity in Eli Lilly’s stock. As financial entities continue to adjust their holdings, the company remains a focal point for institutional participation. The growing involvement from these firms showcases the pharmaceutical company's role within the broader investment landscape.
